Show simple item record

dc.contributor.authorPoloamina, VI
dc.contributor.authorAbate, W
dc.contributor.authorFejer, Gyorgy
dc.contributor.authorJackson, SK
dc.date.accessioned2022-07-22T12:33:36Z
dc.date.issued2022-07-15
dc.identifier.issn0144-8463
dc.identifier.issn1573-4935
dc.identifier.otherARTN BSR20220251
dc.identifier.urihttp://hdl.handle.net/10026.1/19433
dc.description.abstract

<jats:p>Inflammation is central to several diseases. TLR4 mediates inflammation by recognising and binding to bacterial lipopolysaccharides and interacting with other proteins in the TLR4 signalling pathway. Although there is extensive research on TLR4-mediated inflammation, there are gaps in understanding its mechanisms. Recently, TLR4 co-localised with LPCAT2, a lysophospholipid acetyltransferase. LPCAT2 is already known to influence lipopolysaccharide-induced inflammation; however, the mechanism of LPCAT2 influencing lipopolysaccharide-mediated inflammation is not understood. This study combined computational analysis with biochemical analysis to investigate the influence of LPCAT2 on lysine acetylation in LPS-treated RAW264.7 cells. The results suggest for the first time that LPCAT2 influences lysine acetylation in LPS-treated RAW264.7 cells. Moreover, we detected acetylated lysine residues on TLR4. This study lays a foundation for further research on the role of lysine acetylation on TLR4 signalling. Moreover, further research is required to characterise LPCAT2 as a protein acetyltransferase.</jats:p>

dc.format.extentBSR20220251-
dc.format.mediumPrint
dc.languageen
dc.language.isoeng
dc.publisherPortland Press Ltd.
dc.subjectacetylation/deacetylation
dc.subjectacetyltransferases
dc.subjectbioinformatics
dc.subjectimmunomodulation
dc.subjectinflammation
dc.subjecttoll-like receptors
dc.subject1-Acylglycerophosphocholine O-Acyltransferase
dc.subjectAcetylation
dc.subjectAcetyltransferases
dc.subjectAnimals
dc.subjectInflammation
dc.subjectLipopolysaccharides
dc.subjectLysine
dc.subjectMice
dc.subjectRAW 264.7 Cells
dc.subjectToll-Like Receptor 4
dc.titlePossible Regulation of Toll-Like Receptor 4 By Lysine Acetylation Through LPCAT2 Activity in RAW264.7 Cells.
dc.typejournal-article
dc.typeJournal Article
dc.typeResearch Support, Non-U.S. Gov't
plymouth.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000830073400001&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008
plymouth.issue7
plymouth.volume42
plymouth.publication-statusPublished
plymouth.journalBioscience Reports
dc.identifier.doi10.1042/bsr20220251
plymouth.organisational-group/Plymouth
plymouth.organisational-group/Plymouth/Faculty of Health
plymouth.organisational-group/Plymouth/Faculty of Health/School of Biomedical Sciences
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA
plymouth.organisational-group/Plymouth/REF 2021 Researchers by UoA/UoA01 Clinical Medicine
plymouth.organisational-group/Plymouth/Research Groups
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)
plymouth.organisational-group/Plymouth/Research Groups/Institute of Translational and Stratified Medicine (ITSMED)/CBR
plymouth.organisational-group/Plymouth/Users by role
plymouth.organisational-group/Plymouth/Users by role/Academics
plymouth.organisational-group/Plymouth/Users by role/Researchers in ResearchFish submission
dc.publisher.placeEngland
dcterms.dateAccepted2022-06-22
dc.rights.embargodate2022-7-23
dc.identifier.eissn1573-4935
dc.rights.embargoperiodNot known
rioxxterms.versionofrecord10.1042/bsr20220251
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserved
rioxxterms.licenseref.startdate2022-06-23
rioxxterms.typeJournal Article/Review


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record


All items in PEARL are protected by copyright law.
Author manuscripts deposited to comply with open access mandates are made available in accordance with publisher policies. Please cite only the published version using the details provided on the item record or document. In the absence of an open licence (e.g. Creative Commons), permissions for further reuse of content should be sought from the publisher or author.
Theme by 
Atmire NV